(Reuters) – The U.S. Food and Drug Administration said on Wednesday there was a shortage of the drug Adderall, a treatment for attention deficit hyperactivity disorder (ADHD).
(Reporting by Bhanvi Satija in Bengaluru)
U.S. FDA announces shortage of ADHD drug Adderall
Oct 12, 2022 | 4:31 PM
